BLSH vs CHYM Stock Comparison

CHYM currently leads BLSH in this stock comparison, with AIQ scores of 67 vs 45. The clearest difference is momentum, while BLSH has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 22 points
BLSH
Technology
vs
CHYM
Technology
BLSH
Bullish
Price
$22.49
Day move
-2.93%
AIQ Score
45/100
Best edge
Value
Sector
Technology
CHYM
Chime Financial, Inc. Class A Common Stock
Leads
Price
$33.55
Day move
+1.57%
AIQ Score
67/100
Best edge
Momentum
Sector
Technology

What is the main difference between BLSH and CHYM?

CHYM leads the current stock comparison as Chime Financial, Inc. Class A Common Stock, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bullish vs Chime Financial, Inc. Class A Common Stock

Data as of Nov 15, 2026· market close· Technology· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

CHYM leads

CHYM leads by 22 AIQ points, primarily on Momentum and Quality, and the lead has widened from 12 points over 30 sessions. Wall Street currently favors BLSH on target upside.

Competitive: 4 of 6 evidence groups support CHYM, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
BLSH

Bullish

AIQ Score
45/100
AIQ Edge Score
3/10
CHYM

Chime Financial, Inc. Class A Common Stock

Leads
AIQ Score
67/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors CHYM over BLSH, 67 versus 45 as of Nov 15, 2026. CHYM's advantage is driven primarily by stronger momentum and quality, while BLSH holds the stronger value profile. CHYM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BLSH. 4 of 6 covered evidence groups favor CHYM today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. CHYM lead: Strengthening — the AIQ differential moved from 12 to 22 points over 30 sessions.

Compare Bullish and Chime Financial, Inc. Class A Common Stock across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

BLSH
-66.9%
CHYM
+11.8%

Price return comparison

Growth of $10,000, price only

BLSH $3,307 · CHYM $11,183

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare BLSH and CHYM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BLSH advantage
0
CHYM advantage
  • Momentum36 vs 83
    CHYM +47
  • Value80 vs 40
    BLSH +40
  • Quality41 vs 74
    CHYM +33
  • Risk Resilience31 vs 52
    CHYM +21

4 of 6 evidence groups favor CHYM. CHYM’s edge is concentrated in momentum and quality; BLSH keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BLSH0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • MACD Bullish Crossover — bullish, momentum, short horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
CHYM+1 AIQ

Largest factor move: Momentum +3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.56x)
  • RSI Overbought — bearish, momentum, short horizon
  • Stochastic Overbought Rollover — bearish, momentum, short horizon

CHYM's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BLSH and CHYM both carry a full feed there.

The central trade-off

CHYM (Chime Financial, Inc. Class A Common Stock): the stronger current systematic profile, led by momentum and quality.

BLSH (Bullish): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 90.5% against 37%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

CHYM

CHYM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CHYM

CHYM on combined revenue and EPS growth.

Value

BLSH

BLSH on the peer-relative Value factor, by 40 points.

Momentum

CHYM

CHYM on the Momentum factor, by 47 points.

Lower downside

CHYM

CHYM on Risk Resilience, by 21 points.

Analyst upside

BLSH

BLSH on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors CHYM, analyst targets favor BLSH. That disagreement is the most useful thing on this page.

MeasureBLSHCHYMNote
Implied upside to target+93.4%+20.8%BLSH has more room
Target dispersion+36.8%+46.9%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering1424Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor CHYM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreCHYM45 vs 67
FundamentalsCHYMon balancerevenue growth -99.8% vs 7.2%; EPS growth 53.8% vs 50.1%; TTM ROE -11.2% vs 2.8%; operating margin 0% vs 1.8% — CHYM takes 3 of 4 decided legs, not all of them
ValuationBLSHValue 80 vs 40
TechnicalsCHYMPrice vs 50-day -27.5% vs 12.1%; vs 200-day -28.9% vs 39.6%
Risk ResilienceCHYMRisk Resilience 31 vs 52
Analyst expectationsBLSHTarget upside 93.4% vs 20.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BLSH and CHYM and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 22 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CHYM.

How the comparison changed

45 daily snapshots · Sep 14 – Nov 13

CHYM lead: Strengthening — the AIQ differential moved from 12 to 22 points over 30 sessions.

Sep 14BLSH leads above the line · CHYM leads belowNov 13
Today
CHYM +22
45 vs 67
7 sessions ago
CHYM +19
46 vs 65
30 sessions ago
CHYM +12
51 vs 63
90 sessions ago
Not covered

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BLSHConflicted

2 bullish / 3 bearish / 1 neutral, conflicted

Only BLSH

  • Death Cross Active — bearish, trend, long horizon (1.98%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Bullish Crossover — bullish, momentum, short horizon
CHYMConflicted

7 bullish / 2 bearish / 2 neutral, conflicted

Only CHYM

  • Golden Cross Active — bullish, trend, long horizon (24.58%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.56x)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • Stochastic Overbought Rollover — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, MACD Histogram Expanding Bullish.

CHYM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BLSHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.93%, AIQ 0 points).

CHYMConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +1.57%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BLSH closes the Momentum gap — currently 47 points behind, the largest single contributor to CHYM's edge.
  2. 2BLSH's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3CHYM's conflicting signal state resolves bearish — it currently carries 7 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CHYM leads on balance
MetricBLSHCHYM
Revenue growth (YoY)-99.8%7.2%
EPS growth (YoY)53.8%50.1%
Gross margin0%88.9%
Operating margin0%1.8%
Return on equity (TTM)-11.2%2.8%
Debt to equity0.210.07

Performance

CHYM leads 6 of 6 windows
MetricBLSHCHYM
1 week (5 sessions)5.5%7.1%
1 month (20 sessions)-23.7%13.1%
3 months (63 sessions)-9.9%6.7%
6 months (126 sessions)-36.9%89.7%
Year to date-40.6%33.3%
1 year (252 sessions)-50.6%66.1%

Technicals

CHYM has the stronger structure
MetricBLSHCHYM
RSI (14)36.670.5
ADX (14)35.321.6
Price vs 50-day-27.5%12.1%
Price vs 200-day-28.9%39.6%
Volatility (1M, annualized)90.5%37%

Risk

CHYM is the more resilient
MetricBLSHCHYM
Beta2.781.74
Sharpe ratio-0.481.16
Sortino ratio-0.691.8
Max drawdown-57.2%-41.1%
Current drawdown-53.6%-2.9%
Annualized volatility75.4%60.7%
Value at risk (95%)-7.5%-5.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BLSH or CHYM?

On the Algovestiq AIQ Score, CHYM is the stronger of the two as of Nov 15, 2026, scoring 67 against BLSH's 45. The edge comes from momentum and quality. BLSH is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BLSH or CHYM the better buy right now?

CHYM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor CHYM over BLSH?

The composite weights Quality, Value, Momentum and Risk Resilience. CHYM leads Momentum by 47 points; BLSH leads Value by 40 points; CHYM leads Quality by 33 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BLSH or CHYM?

Analyst price targets imply +93.4% upside for BLSH and +20.8% for CHYM, so the Street currently favors BLSH. That points the opposite way to the AIQ Score, which favors CHYM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BLSH or CHYM?

BLSH is the better-valued of the two on the peer-relative Value factor. BLSH on the peer-relative Value factor, by 40 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BLSH or CHYM?

CHYM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BLSH or CHYM?

CHYM on the Momentum factor, by 47 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BLSH or CHYM?

CHYM is the more resilient of the two, so the other name carries the higher downside risk. CHYM on Risk Resilience, by 21 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BLSH more profitable than CHYM?

CHYM leads on the comparable margin measures — gross margin 0% vs 88.9%; operating margin 0% vs 1.8%; ttm roe -11.2% vs 2.8%.

Is CHYM's lead over BLSH getting stronger or weaker?

CHYM lead: Strengthening — the AIQ differential moved from 12 to 22 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has not changed hands in that window.

What would change the BLSH vs CHYM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BLSH closes the Momentum gap — currently 47 points behind, the largest single contributor to CHYM's edge; BLSH's Death Cross Active resolves — a bearish trend rule currently active against it; CHYM's conflicting signal state resolves bearish — it currently carries 7 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BLSH and CHYM?

BLSH: 2 bullish / 3 bearish / 1 neutral, conflicted. CHYM: 7 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BLSH is Death Cross Active (bearish, long horizon). On CHYM it is Golden Cross Active (bullish, long horizon).

Compare BLSH and CHYM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.